Stephen M. Graham is co-chair of Fenwick & West’s Life Sciences Practice and is a partner in the corporate group. He is resident in the firm’s Seattle office, where he is the Managing Partner. Mr. Graham focuses his practice on emerging and established high growth companies in the areas of company formations, private placements, public offerings, private and public mergers and acquisitions, and general corporate matters, including advising boards of directors, audit, compensation, and nominating/corporate governance committees; preparation and filing of periodic SEC reports; and other securities law compliance, including the Sarbanes-Oxley Act and disclosure issues with respect to Rule 10b-5 and Regulation FD. Mr. Graham has represented companies such as Immunex, ICOS, Corixa, and Corus in numerous public offerings, a wide variety of merger and acquisition transactions, and private offerings of debt and equity. Currently, his clients include Acucela, Amnis, Cardiac Dimensions, LipoSonix, Napera Networks, Spaltudaq, SonoSite, Targeted Genetics and VLST Steve received his J.D. from Yale Law School.